260 related articles for article (PubMed ID: 11849625)
21. Serum levels of interleukin-6 and C-reactive protein correlate with body mass index across the broad range of obesity.
Khaodhiar L; Ling PR; Blackburn GL; Bistrian BR
JPEN J Parenter Enteral Nutr; 2004; 28(6):410-5. PubMed ID: 15568287
[TBL] [Abstract][Full Text] [Related]
22. The anti-inflammatory effects of exercise training in patients with type 2 diabetes mellitus.
Kadoglou NP; Iliadis F; Angelopoulou N; Perrea D; Ampatzidis G; Liapis CD; Alevizos M
Eur J Cardiovasc Prev Rehabil; 2007 Dec; 14(6):837-43. PubMed ID: 18043308
[TBL] [Abstract][Full Text] [Related]
23. Association between serum values of C-reactive protein and cytokine production in whole blood of patients with type 2 diabetes.
Castoldi G; Galimberti S; Riva C; Papagna R; Querci F; Casati M; Zerbini G; Caccianiga G; Ferrarese C; Baldoni M; Valsecchi MG; Stella A
Clin Sci (Lond); 2007 Jul; 113(2):103-8. PubMed ID: 17362204
[TBL] [Abstract][Full Text] [Related]
24. Circulating IL-8 levels are increased in patients with type 2 diabetes and associated with worse inflammatory and cardiometabolic profile.
Cimini FA; Barchetta I; Porzia A; Mainiero F; Costantino C; Bertoccini L; Ceccarelli V; Morini S; Baroni MG; Lenzi A; Cavallo MG
Acta Diabetol; 2017 Oct; 54(10):961-967. PubMed ID: 28836077
[TBL] [Abstract][Full Text] [Related]
25. The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome.
Ciftci TU; Kokturk O; Bukan N; Bilgihan A
Cytokine; 2004 Oct; 28(2):87-91. PubMed ID: 15381186
[TBL] [Abstract][Full Text] [Related]
26. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.
Pradhan AD; Manson JE; Rifai N; Buring JE; Ridker PM
JAMA; 2001 Jul; 286(3):327-34. PubMed ID: 11466099
[TBL] [Abstract][Full Text] [Related]
27. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients.
Navarro JF; Mora C; Gómez M; Muros M; López-Aguilar C; García J
Nephrol Dial Transplant; 2008 Mar; 23(3):919-26. PubMed ID: 17911088
[TBL] [Abstract][Full Text] [Related]
28. Skeletal muscle interleukin-6 and tumor necrosis factor-alpha release in healthy subjects and patients with type 2 diabetes at rest and during exercise.
Febbraio MA; Steensberg A; Starkie RL; McConell GK; Kingwell BA
Metabolism; 2003 Jul; 52(7):939-44. PubMed ID: 12870175
[TBL] [Abstract][Full Text] [Related]
29. Idiopathic venous thrombosis is related to systemic inflammatory response and to increased levels of circulating markers of endothelial dysfunction.
Jezovnik MK; Poredos P
Int Angiol; 2010 Jun; 29(3):226-31. PubMed ID: 20502419
[TBL] [Abstract][Full Text] [Related]
30. Tumor necrosis factor-alpha-induced insulin resistance may mediate the hepatitis C virus-diabetes association.
Knobler H; Zhornicky T; Sandler A; Haran N; Ashur Y; Schattner A
Am J Gastroenterol; 2003 Dec; 98(12):2751-6. PubMed ID: 14687828
[TBL] [Abstract][Full Text] [Related]
31. The role of vascular endothelial growth factor, tumor necrosis factor alpha and interleukin-6 in pathogenesis of diabetic retinopathy.
Myśliwiec M; Balcerska A; Zorena K; Myśliwska J; Lipowski P; Raczyńska K
Diabetes Res Clin Pract; 2008 Jan; 79(1):141-6. PubMed ID: 17716775
[TBL] [Abstract][Full Text] [Related]
32. Cytokines, Type 2 DM and the Metabolic Syndrome.
Ogbera A; Azenabor A; Ogundahunsi OA; Ekun AO; Adejumo EN
Nig Q J Hosp Med; 2013; 23(4):318-22. PubMed ID: 27276762
[TBL] [Abstract][Full Text] [Related]
33. Immune activation is associated with reduced skeletal muscle mass and physical function in chronic heart failure.
Toth MJ; Ades PA; Tischler MD; Tracy RP; LeWinter MM
Int J Cardiol; 2006 May; 109(2):179-87. PubMed ID: 16024109
[TBL] [Abstract][Full Text] [Related]
34. Cytokine profile of peripheral blood in type 2 diabetes mellitus patients with diabetic retinopathy.
Lee JH; Lee W; Kwon OH; Kim JH; Kwon OW; Kim KH; Lim JB
Ann Clin Lab Sci; 2008; 38(4):361-7. PubMed ID: 18988929
[TBL] [Abstract][Full Text] [Related]
35. CRP, but not TNF-α or IL-6, decreases after weight loss in patients with morbid obesity exposed to intensive weight reduction and balneological treatment.
Rość D; Adamczyk P; Boinska J; Szafkowski R; Ponikowska I; Stankowska K; Góralczyk B; Ruszkowska-Ciastek B
J Zhejiang Univ Sci B; 2015 May; 16(5):404-11. PubMed ID: 25990058
[TBL] [Abstract][Full Text] [Related]
36. Increased levels of proinflammatory cytokines in children with family history of coronary artery disease.
E L; Fragakis N; Ioannidou E; Bounda A; Theodoridou S; Klonizakis P; Garipidou V
Clin Cardiol; 2010 Apr; 33(4):E6-10. PubMed ID: 20229495
[TBL] [Abstract][Full Text] [Related]
37. Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers.
Singh S; Verma SK; Kumar S; Ahmad MK; Nischal A; Singh SK; Dixit RK
Immunol Lett; 2018 Apr; 196():1-10. PubMed ID: 29329680
[TBL] [Abstract][Full Text] [Related]
38. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients.
Kopp HP; Kopp CW; Festa A; Krzyzanowska K; Kriwanek S; Minar E; Roka R; Schernthaner G
Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1042-7. PubMed ID: 12714437
[TBL] [Abstract][Full Text] [Related]
39. Impact of early inflammatory cytokine elevation after commencement of PD-1 inhibitors to predict efficacy in patients with non-small cell lung cancer.
Ozawa Y; Amano Y; Kanata K; Hasegwa H; Matsui T; Kakutani T; Koyauchi T; Tanahashi M; Niwa H; Yokomura K; Suda T
Med Oncol; 2019 Mar; 36(4):33. PubMed ID: 30825015
[TBL] [Abstract][Full Text] [Related]
40. Plasma cytokine levels predict mortality in patients with acute renal failure.
Simmons EM; Himmelfarb J; Sezer MT; Chertow GM; Mehta RL; Paganini EP; Soroko S; Freedman S; Becker K; Spratt D; Shyr Y; Ikizler TA;
Kidney Int; 2004 Apr; 65(4):1357-65. PubMed ID: 15086475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
